US FDA to Reconvene Experts ' Meeting for Amylyx ALS Drug US FDA to Reconvene Experts ' Meeting for Amylyx ALS Drug

The US Food and Drug Administration will reconvene a meeting of its outside experts to review Amylyx Pharmaceuticals ' application for its amyotrophic lateral sclerosis treatment, the company said Tuesday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news